SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-023747
Filing Date
2020-11-13
Accepted
2020-11-13 09:31:27
Documents
59
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atos20200930_10q.htm 10-Q 862908
2 EXHIBIT 31.1 ex_203415.htm EX-31.1 11805
3 EXHIBIT 31.2 ex_203416.htm EX-31.2 12357
4 EXHIBIT 32.1 ex_203417.htm EX-32.1 6366
5 EXHIBIT 32.2 ex_203418.htm EX-32.2 6911
  Complete submission text file 0001437749-20-023747.txt   3891945

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT atos-20200930.xml EX-101.INS 669981
7 XBRL TAXONOMY EXTENSION SCHEMA atos-20200930.xsd EX-101.SCH 43336
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atos-20200930_cal.xml EX-101.CAL 30539
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atos-20200930_def.xml EX-101.DEF 283939
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atos-20200930_lab.xml EX-101.LAB 249740
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atos-20200930_pre.xml EX-101.PRE 308304
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35610 | Film No.: 201309469
SIC: 2834 Pharmaceutical Preparations